💊 Gland Pharma Secures Danish GMP Certification for Aseptic Products

**Gland Pharma Ltd.** has achieved another regulatory milestone by securing a **GMP (Good Manufacturing Practices) compliance certificate** from the **Danish Medicines Agency** for its **Pashamylaram facility**. The certification covers the manufacturing of **aseptically prepared powder for injection, infusion, and inhalation**, intended for markets outside the European Economic Area. This development, announced on **July 11, 2025**, reinforces Gland Pharma’s position as a trusted global pharmaceutical supplier and supports its ambitions to deepen its presence in European and international markets. The certification not only reflects the company's high-quality manufacturing standards but also paves the way for **marketing authorizations in regulated jurisdictions**. The Pashamylaram facility plays a crucial role in Gland Pharma’s injectable manufacturing capabilities, and this validation from a stringent European authority adds significant weight to its global compliance credentials. --- **Disclaimer:** For informational purposes only. Not a recommendation to buy/sell. **Source:** Company communication to BSE and NSE dated July 11, 2025.